| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.52B | 4.90B | 4.07B | 3.19B | 2.48B | 2.21B |
| Gross Profit | 3.24B | 3.62B | 2.77B | 2.07B | 1.52B | 1.26B |
| EBITDA | -6.22M | 149.76M | -589.25M | -281.10M | -901.27M | -475.78M |
| Net Income | -457.28M | -17.36M | -771.66M | -463.35M | -1.04B | -511.67M |
Balance Sheet | ||||||
| Total Assets | 4.11B | 4.16B | 4.21B | 4.60B | 4.79B | 5.43B |
| Cash, Cash Equivalents and Short-Term Investments | 2.64B | 2.48B | 2.74B | 2.85B | 3.04B | 4.20B |
| Total Debt | 950.88M | 836.68M | 1.03B | 504.44M | 450.67M | 178.12M |
| Total Liabilities | 1.49B | 1.50B | 1.57B | 1.21B | 1.11B | 804.21M |
| Stockholders Equity | 2.62B | 2.66B | 2.65B | 3.39B | 3.68B | 4.62B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 63.18M | -387.38M | -413.56M | -1.71B | -854.95M |
| Operating Cash Flow | 0.00 | 78.89M | -369.09M | -331.22M | -1.00B | -493.48M |
| Investing Cash Flow | 0.00 | -181.98M | -52.41M | -85.01M | -508.68M | -610.36M |
| Financing Cash Flow | 0.00 | -158.63M | 322.64M | 217.61M | 363.05M | 4.83B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥9.45B | 14.92 | ― | 1.48% | 17.83% | 34.25% | |
67 Neutral | ¥9.81B | 10.50 | ― | 0.70% | 9.78% | -23.98% | |
66 Neutral | ¥4.93B | 13.38 | ― | ― | 7.60% | 19.13% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | ¥13.02B | 60.03 | ― | ― | 14.63% | -760.87% | |
57 Neutral | ¥47.37B | 107.87 | ― | ― | 29.56% | 86.66% | |
53 Neutral | ¥9.62B | -554.87 | ― | ― | 22.18% | 28.27% |
SpiderPlus&Co. plans to substantially reduce its share capital and legal capital surplus and reclassify these amounts to other capital surplus as part of a broader capital restructuring. The move, which does not change the total number of issued shares, is designed to enhance financial soundness and give the company more agility and flexibility in future capital policy.
Following these reductions, the company will transfer ¥2,645,596,666 from other capital surplus to retained earnings brought forward to eliminate its accumulated deficit. As this is an internal reallocation within net assets, SpiderPlus&Co. expects no change in total net assets and no impact on business performance, with the plan subject to shareholder approval at the March 25, 2026 general meeting.
The most recent analyst rating on (JP:4192) stock is a Hold with a Yen315.00 price target. To see the full list of analyst forecasts on SpiderPlus & Co. stock, see the JP:4192 Stock Forecast page.
SpiderPlus & Co. said it will book an extraordinary loss of 43 million yen in its non-consolidated financial results for fiscal 2025, stemming from a loss on valuation of shares in its consolidated subsidiary SpiderPlus Vietnam. The impairment follows an assessment under Japan’s Accounting Standard for Financial Instruments, reflecting a review of the subsidiary’s business progress and resulting in a write-down of its equity value.
The company emphasized that this loss is confined to its non-consolidated accounts and does not affect consolidated performance, signaling that the group’s overall earnings and operations remain intact. For stakeholders, the move indicates a conservative stance on valuing overseas expansion efforts, while confirming that the impact on group-level profitability and financial health is limited.
The most recent analyst rating on (JP:4192) stock is a Hold with a Yen315.00 price target. To see the full list of analyst forecasts on SpiderPlus & Co. stock, see the JP:4192 Stock Forecast page.
SpiderPlus & Co. reported fiscal 2025 consolidated net sales of ¥4,895 million, essentially matching its forecast as uptake of its SPIDER+ service and related BPO and professional solutions progressed as planned. Through efficient investment and cost controls, the company narrowed its operating loss to ¥10 million, substantially better than its earlier projection of a ¥58 million loss.
Compared with fiscal 2024, net sales rose 20.2% on strong stock revenue from optional SPIDER+ functions and broader rollout to previously non-adopting users at existing clients. Profit metrics improved sharply, with operating loss, ordinary loss, and loss attributable to owners of parent all shrinking, signaling strengthening business fundamentals and improved earnings quality for stakeholders despite the company remaining marginally loss-making.
The most recent analyst rating on (JP:4192) stock is a Hold with a Yen315.00 price target. To see the full list of analyst forecasts on SpiderPlus & Co. stock, see the JP:4192 Stock Forecast page.
SpiderPlus & Co. reported consolidated net sales of ¥4.9 billion for the year ended December 31, 2025, up 20.2% year on year, while trimming its net loss attributable to owners of the parent to ¥17 million from ¥771 million. The company maintained a solid equity ratio of 64.0%, saw cash and cash equivalents fall to ¥2.48 billion amid reduced financing inflows, and kept its dividend at zero, signaling a continued emphasis on reinvestment over shareholder payouts.
Non-consolidated results were buoyed by growth in annual recurring revenue, driven by an increase in new SPIDERPLUS users and higher revenue per contracted company through additional optional features. Management cited strategic investments and disciplined cost control as key drivers behind the swing from operating and ordinary losses in the prior year toward near break-even, and it forecast further top-line expansion in 2026 with net sales projected to rise about 20% to ¥5.9 billion and a return to positive operating income.
The most recent analyst rating on (JP:4192) stock is a Hold with a Yen315.00 price target. To see the full list of analyst forecasts on SpiderPlus & Co. stock, see the JP:4192 Stock Forecast page.